Effect of amphotericin B lipid formulation on immune response in aspergillosis

International Journal of Pharmaceutics

Volumn 188, Issue 1, 1999, Pages 19-30

  Saxena, Sandeep ^a   Bhatnagar, P K ^b   Ghosh, P C ^a   Sarma, P Usha ^b  

^a UNIVERSITY OF DELHI   (India)

^b CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

Amphotericin B; Aspergillus fumigatus; Cytokines; Immuneregulation; Lesions; Sterol vesicles

Indexed keywords

AMPHOTERICIN B; CHOLESTEROL HYDROGEN SUCCINATE; GAMMA INTERFERON; IMMUNOGLOBULIN G; INTERLEUKIN 4;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASPERGILLOSIS; ASPERGILLUS FUMIGATUS; CONTROLLED STUDY; EOSINOPHIL; EOSINOPHILIA; HISTOPATHOLOGY; IMMUNE RESPONSE; INTRAVENOUS DRUG ADMINISTRATION; LUNG PARENCHYMA; MACROPHAGE; MALE; MORTALITY; MOUSE; NEPHROTOXICITY; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; SERODIAGNOSIS;

EID: 0032822826     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(99)00200-8     Document Type: Article

References (24)

1. Banerjee B., Madan T., Sharma G.L., Prasad H.K., Nath I., Sarma P.U. Characterization of glycoprotein antigen (45KD) of Aspergillus fumigates. Serodiagn. Immunother. Infect. Dis. 7:1995;147-152.
2. Bodey G.P., Vartivarian S. Aspergillosis. Eur. J. Clin. Microbiol. Infect. Dis. 8:1989;413-437.
3. Cenci E., Mencacci A., Spaccapelo R., Tonnetti L., Mosci P., Enssle K.H., Puccetti P., Romani L., Bistoni F. T helper cell type 1 (Th1)- and (Th2)- like responses are present in mice with gastric candidiasis but protective immunity is associated with Th1 development. J. Infect. Dis. 171:1995;1279-1288.
4. H2 cytokines in mice with invasive aspergillosis. Infect. Immun. 65:1997;564-570.
5. H2 switch is a critical step in the etiology of HIV infection. Immunol. Today. 14:1993;107-111.
6. Kuby J. Immunology. 2nd edn:1994;W.H. Freeman, San Francisco, CA.
7. Kurup V.P., Mauze S., Choi H., Seymour B.W.P., Coffman R.L. A murine model of allergic bronchopulmonary aspergillosis with elevated eosinophils and IgE. J. Immunol. 148:1992;3783-3788.
8. H2 response in BALB/c mice. J. Allergy Clin. Immunol. 93:1994;1013-1020.
9. Kurup V.P., Choi H., Murali P.S., Resnick A., Fink J.N., Coffman R.L. Role of particulate antigens of Aspergillus in murine eosinophilia. Int. Arch. Allergy Immunol. 112:1997;270-278.
10. Kusne S., Torre-Cisneros J., Manez R., Irish W., Martin M., Fung J., Simmons R.L., Starzl T.E. Factors associated with invasive lung aspergillosis and the significance of positive Aspergillus culture after liver transplantation. J. Infect. Dis. 166:1992;1379-1383.
11. McWhinney P.H.M., Kibbler C.C., Hamon M.D., Smith O.P., Gandhi L., Berger L.A., Walesby R.K., Hoffbrand A.V., Prentice H.G. Progress in the diagnosis and management of aspergillosis in bone marrow transplantation: 13 years experience. Clin. Infect. Dis. 17:1993;397-404.
12. Morrison V.A., Haake R.J., Weisdorf D.J. Non-candida fungal infections after bone marrow transplantation: risk factors and outcome. Am. J. Med. 96:1994;497-503.
13. Nagai H., Guo J., Choi H., Kurup V. Interferon-γ and tumor necrosis factor-α protect mice from invasive aspergillosis. J. Infect. Dis. 172:1995;1554-1560.
14. Puccetti P., Mencacci A., Cenci E., Spaccapelo R., Mosci P., Enssle K.H., Romani L., Bistoni F. Cure of murine candidiasis by recombinant soluble interleukin-4 receptor. J. Infect. Dis. 169:1994;1325-1331.
15. Rex J.H., Benett J.E., Gallin J.I., Malech H.L., DeCarlo E.S., Melnick D.A. In vivo interferon-γ therapy augments the in vitro ability of chronic granulomatous disease PMNs to damage Aspergillus hyphae. J. Infect. Dis. 163:1991;849-852.
16. Rinaldi M.G. Invasive aspergillosis. Rev. Infect. Dis. 5:1983;1061-1077.
17. Roilides E., Uhlig K., Venzon D., Pizzo P.A., Walsh T.J. Enhancement of oxidative response and damage caused by human PMNs to Aspergillus fumigatus hypae by granulocyte colony-stimulating factor and gamma interferon. Infect. Immun. 61(4):1993;1185-1193.
18. H1 responses with acquired resistance. Infect. Immun. 59:1991;4647-4654.
19. Romani L., Mencacci A., Grohmann U., Mocci S., Mosci P., Pucetti P., Bistoni F. Neutralizing antibody to interleukin-4 induces systemic protection and T helper type 1-associated immunity in murine candidiasis. J. Exp. Med. 176:1992;19-25.
20. Rosenberg M., Patterson R., Mintzer R., Cooper B.J., Roberts M., Harris K.E. Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis. Ann. Intern. Med. 86:1997;405-414.
21. Saxena, S., Ghosh, P.C., 1998. Pharmacokinetics of amphotericin B delivered through cholesterol hemisuccinate vesicles in normal and A. fumigatus infected mice. J. Antimicrob. Chemother., in press.
22. Saxena S., Khan J.A., Ghosh P.C. Toxicity and therapeutic efficacy of amphotericin B delivered through cholesterol hemisuccinate vesicles in treatment of experimental murine aspergillosis. J. Antimicrob. Chemother. 42:1998;635-642.
23. Walsh T.J., Pizzo P.A. Aspergillosis. Hoeprich P.D., Jordan C., Ronald A.R. Infectious Diseases. 5th edn:1994;541-547 Lippincott, Philadelphia, PA.
24. Wang L.H., Fielding R.M., Smith P.C., Guo L.S.S. Comparative tissue distribution and elimination of amphotericin B colloidal dispersion (Amphocil) and fungizone after repeated dosing in rats. Pharm. Res. 12:1995;275-283.